Coronavirus Recovery: advice and latest information
Institute of Life Science 1 internal Atrium view up.jpg
Dr Katherine Chapman

Dr Katherine Chapman

Lecturer in Applied Medical Sciences and Medical Pharmacology, Biomedical Sciences

Telephone number

+44 (0) 1792 295056

Welsh language proficiency

Basic Welsh Speaker

Research Links

About

Kate was awarded her BSc in Biochemistry from the University of Bath in 2010, before joining the In Vitro Toxicology Group at Swansea University in the same year to commence her PhD studies. Funded by the National Centre for the 3Rs (NC3Rs) and supervised by Professor Gareth Jenkins, Kate’s PhD centred on the improvement of existing in vitro genotoxicity tests. This involved the development of chronic dosing regimens and 3D tissue culture models.

Following the completion of her PhD laboratory work in 2014, Kate remained within the In Vitro Toxicology Group as a Postdoctoral Researcher, developing a novel in vitro carcinogenicity tool as a potential replacement for the two-year rodent bioassay. From her research activity, Kate has developed a keen interest in animal replacement science, specifically the potential of novel in vitro alternatives in furthering medical research.

Kate is currently a Lecturer in Applied Medical Sciences and Medical Pharmacology at Swansea University Medical School, commencing this role in 2018. Kate is Deputy Examinations Officer and leads several modules. Kate also contributes to teaching on other degree courses within the Medical School, such as the BSc Genetics and Biochemistry programmes and MSc Genomic Medicine and Nanomedicine programmes. Kate collaborates with and provides training to scientists at other institutions, most notably at the Thailand Institute of Scientific and Technological Research.

Career Highlights

Award Highlights

Kate has been awarded several national and international prizes during her career to date, including the international Lush Young Researcher Prize (2016), as well as the Welsh Livery Guild Travel Scholarship and Best New Investigator Platform Presentation at the USA EEMGS Meeting (2014). Kate has also been the recipient of several small grants, including those awarded by the UK Environmental Mutagen Society and the NC3Rs.